News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,881 Results
Type
Article (20469)
Company Profile (126)
Press Release (244277)
Multimedia
Podcasts (37)
Webinars (14)
Section
Business (77989)
Career Advice (949)
Deals (15566)
Drug Delivery (78)
Drug Development (24045)
Employer Resources (145)
FDA (4416)
Job Trends (7121)
News (122901)
Policy (9423)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1546)
Academic (2)
Accelerated approval (10)
Adcomms (16)
Allergies (32)
Alliances (21483)
ALS (61)
Alzheimer's disease (786)
Antibody-drug conjugate (ADC) (126)
Approvals (4567)
Artificial intelligence (272)
Autoimmune disease (53)
Automation (22)
Bankruptcy (126)
Best Places to Work (5822)
BIOSECURE Act (13)
Biosimilars (86)
Biotechnology (71)
Bladder cancer (58)
Brain cancer (23)
Breast cancer (229)
Cancer (1751)
Cardiovascular disease (171)
Career advice (857)
Career pathing (37)
CAR-T (112)
CDC (18)
Celiac Disease (1)
Cell therapy (294)
Cervical cancer (12)
Clinical research (20019)
Collaboration (837)
Compensation (223)
Complete response letters (20)
COVID-19 (1079)
CRISPR (48)
C-suite (512)
Cystic fibrosis (69)
Data (2393)
Decentralized trials (1)
Denatured (23)
Depression (53)
Diabetes (160)
Diagnostics (2951)
Digital health (20)
Diversity (10)
Diversity, equity & inclusion (37)
Drug discovery (131)
Drug pricing (66)
Drug shortages (5)
Duchenne muscular dystrophy (85)
Earnings (21747)
Editorial (22)
Employer branding (23)
Employer resources (122)
Events (39621)
Executive appointments (617)
FDA (5519)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (7)
Funding (803)
Gene editing (90)
Generative AI (28)
Gene therapy (200)
GLP-1 (375)
Government (1549)
Guidances (154)
Healthcare (6551)
HIV (28)
Huntington's disease (22)
IgA nephropathy (24)
Immunology and inflammation (63)
Immuno-oncology (17)
Indications (34)
Infectious disease (1185)
Inflammatory bowel disease (87)
Inflation Reduction Act (9)
Influenza (43)
Intellectual property (101)
Interviews (140)
IPO (7796)
IRA (19)
Job creations (1455)
Job search strategy (725)
JPM (26)
Kidney cancer (2)
Labor market (81)
Layoffs (203)
Leadership (20)
Legal (1972)
Liver cancer (31)
Longevity (10)
Lung cancer (236)
Lymphoma (164)
Machine learning (21)
Management (43)
Manufacturing (343)
MASH (41)
Medical device (4234)
Medtech (4255)
Mergers & acquisitions (8486)
Metabolic disorders (402)
Multiple sclerosis (74)
NASH (10)
Neurodegenerative disease (133)
Neuropsychiatric disorders (26)
Neuroscience (1319)
Neurotech (1)
NextGen: Class of 2026 (2775)
Non-profit (1800)
Now hiring (64)
Obesity (201)
Opinion (129)
Ovarian cancer (51)
Pain (85)
Pancreatic cancer (83)
Parkinson's disease (117)
Partnered (22)
Patents (175)
Patient recruitment (151)
Peanut (18)
People (31424)
Pharmaceutical (25)
Pharmacy benefit managers (4)
Phase 1 (6010)
Phase 2 (8525)
Phase 3 (7492)
Pipeline (1937)
Policy (112)
Postmarket research (677)
Preclinical (3107)
Press Release (61)
Prostate cancer (83)
Psychedelics (28)
Radiopharmaceuticals (102)
Rare diseases (299)
Real estate (2894)
Recruiting (58)
Regulatory (7404)
Reports (43)
Research institute (1387)
Resumes & cover letters (118)
Rett syndrome (3)
RNA editing (9)
RSV (44)
Schizophrenia (82)
Series A (138)
Series B (102)
Service/supplier (7)
Sickle cell disease (44)
Special edition (10)
Spinal muscular atrophy (59)
Sponsored (17)
Startups (2243)
State (1)
Stomach cancer (7)
Supply chain (44)
Tariffs (22)
The Weekly (14)
Vaccines (341)
Venture capital (60)
Weight loss (112)
Women's health (40)
Worklife (18)
Date
Last 7 days (248)
Last 30 days (858)
Last 365 days (12181)
2026 (1208)
2025 (12378)
2024 (14872)
2023 (17167)
2022 (20564)
2021 (23479)
2020 (21996)
2019 (18807)
2018 (13891)
2017 (13202)
2016 (12492)
2015 (14257)
2014 (10280)
2013 (8665)
2012 (9211)
2011 (9290)
2010 (8645)
Location
Africa (349)
Alabama (39)
Alaska (4)
Arizona (123)
Arkansas (4)
Asia (14773)
Australia (2398)
California (4374)
Canada (1218)
China (348)
Colorado (194)
Connecticut (169)
Delaware (201)
Europe (34283)
Florida (703)
Georgia (121)
Hawaii (2)
Idaho (18)
Illinois (301)
India (37)
Indiana (291)
Iowa (12)
Japan (189)
Kansas (55)
Kentucky (19)
Louisiana (11)
Maine (52)
Maryland (451)
Massachusetts (3327)
Michigan (192)
Minnesota (223)
Mississippi (6)
Missouri (55)
Montana (7)
Nebraska (14)
Nevada (57)
New Hampshire (22)
New Jersey (1328)
New Mexico (18)
New York (1389)
North Carolina (764)
North Dakota (9)
Northern California (2103)
Ohio (139)
Oklahoma (9)
Oregon (21)
Pennsylvania (764)
Puerto Rico (6)
Rhode Island (18)
South America (444)
South Carolina (20)
Southern California (1640)
Tennessee (86)
Texas (776)
United States (16385)
Utah (122)
Vermont (1)
Virginia (122)
Washington D.C. (34)
Washington State (335)
West Virginia (2)
Wisconsin (87)
Wyoming (1)
264,881 Results for "grace science llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arrayjet Opens First US Printing Suite in Bend, Oregon, in Strategic Collaboration with Grace Bio Labs
January 7, 2026
·
1 min read
FDA
Grace Science, LLC Selected by FDA to Participate in the START Pilot Program for GS-100 Gene Therapy for NGLY1 Deficiency and Announcement of the Successful Treatment of the 2nd Patient
Grace Science, LLC announced today that the IND for GS-100, an AAV9 gene therapy for NGLY1 Deficiency, was accepted into the FDA’s Support for clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program.
June 3, 2024
·
3 min read
Press Releases
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference
November 18, 2025
·
3 min read
Press Releases
Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update
November 14, 2025
·
17 min read
Press Releases
Grace Therapeutics Announces Abstract Accepted for Presentation at Society of Vascular and Interventional Neurology Annual Meeting
November 11, 2025
·
3 min read
Press Releases
Granata Bio Reports Strong Enrollment Momentum in Pivotal Phase III GRACE Study of Investigational Gonadotropin for Assisted Reproductive Technology
December 4, 2025
·
2 min read
Drug Development
Grace Science, LLC Announces First Patient Treated in Phase 1/2/3 Trial of GS-100, an AAV9 Gene Therapy for NGLY1 Deficiency
Grace Science, LLC announced today that the first patient was dosed in an open-label Phase 1/2/3 clinical trial of GS-100, an AAV9 gene replacement therapy for the treatment of NGLY1 Deficiency.
March 5, 2024
·
2 min read
Business
Andelyn Biosciences and Grace Science, LLC Partner to Tech Transfer Phase I/II/III Manufacturing of a Suspension Process Adeno-Associated Virus (AAV) Gene Therapy for NGLY1 Deficiency
Andelyn Biosciences has partnered with Grace Science, LLC, to tech transfer and manufacture GS-100, a suspension process AAV NGLY1 gene therapy for Phase I/II/III clinical trial material for the treatment of NGLY1 Deficiency.
March 25, 2024
·
3 min read
Press Releases
Medincell Appoints Dr Grace Kim, Chief Strategy Officer, U.S. Finance, to Advance into Next Stage of US Capital Growth
November 11, 2025
·
2 min read
Press Releases
Grace Therapeutics Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104
September 18, 2025
·
8 min read
1 of 26,489
Next
